PulmCCM

Share this post
EBUS was good at differentiating new lung cancer from recurrence
www.pulmccm.org

EBUS was good at differentiating new lung cancer from recurrence

Jul 17, 2011
Share this post
EBUS was good at differentiating new lung cancer from recurrence
www.pulmccm.org

Anraku et al report a series of 40 patients previously treated for lung cancer who underwent endobronchial ultrasound guided transbronchial needle aspiration for new mediastinal or hilar abnormalities between 2008-2010 at University of Toronto.

After EBUS-TBNA of mediastinal/hilar lymph nodes, 28 of 40 were found to have lung cancer. In 21, an identical cell type as their primary cancer suggested recurrence. In 7, the cancer was a new cell type and believed to be a new primary. Ann Thorac Surg 2011;92:251-255.

Share this post
EBUS was good at differentiating new lung cancer from recurrence
www.pulmccm.org
Comments
TopNew

No posts

Ready for more?

© 2023 PulmCCM
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing